Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew D. Goldberg Insider Profile
4 Followers
Andrew D. Goldberg, Director at Tarsus Pharmaceuticals, holds 3.00K shares in Tarsus Pharmaceuticals (Ticker: TARS). Most recently, Andrew D. Goldberg Bought $1,000 shares of Tarsus Pharmaceuticals on Dec 19, 2023 for an estimated value of 18.96K.
Andrew D. Goldberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew D. Goldberg's holdings
Insider Roles
Director
Roles that Andrew D. Goldberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew D. Goldberg
Andrew D. Goldberg's Trading History
List of latest transactions for each holding click on a transaction to see Andrew D. Goldberg's performance on stock
You May Also Like
Andrew D. Goldberg insider profile FAQ
What is the percentage of profitable transactions made by Andrew D. Goldberg?
The percentage of profitable transactions made by Andrew D. Goldberg is ―.
What is the average return per transaction made by Andrew D. Goldberg?
The average return per transaction made by Andrew D. Goldberg is ―.
What stocks does Andrew D. Goldberg hold?
Andrew D. Goldberg holds: TARS stocks.
What was Andrew D. Goldberg’s latest transaction?
Andrew D. Goldberg latest transaction was an Informative Buy of $18.96K.
What was Andrew D. Goldberg's most profitable transaction?
Andrew D. Goldberg’s most profitable transaction was an Informative Buy of TARS stock on December 19, 2023. The return on the trade was 92.40%.
What is Andrew D. Goldberg's role in Tarsus Pharmaceuticals?
Andrew D. Goldberg's role in Tarsus Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.